Genscript Biotech Corporation

HKEX:1548.HK

12.1 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 399.2971,446.4031,397.3341,023.999782.2461,180.971957.615629.058706.693252.397283.579494.558452.607123.857130.749136.464122.067103.7225.68425.637
Short Term Investments 1,328.432481.647499.884228.894458.334222.533243.241137.458173.05148.693141.06170.0561803.0881.18100002.526
Cash and Short Term Investments 1,879.0171,928.052,141.7961,463.7121,255.6631,405.7121,202.5772.382929.172426.524504.554564.614657.544126.945131.93136.464122.067103.7225.68428.163
Net Receivables 130.812217.443132.51104.277102.339142.43992.635141.74863.21173.06749.37667.84334.549255.35123.6320.02221.54716.91413.9412.157
Inventory 50.85753.34651.51559.93549.89844.35834.88631.74524.17916.48614.72412.4298.0726.8785.5674.2374.2682.0252.1361.777
Other Current Assets 142.061259.917387.109347.845104.99348.75942.96253.16592.5163.403102.513104.63344.2788.7215.2333.1866.11310.3552.0081.695
Total Current Assets 2,214.3232,353.1112,468.3521,764.951,497.811,639.061,371.339993.1741,059.643554.046591.253679.463719.506397.895166.36163.909153.995133.01443.76843.792
Non-Current Assets:
Property, Plant & Equipment, Net 813.715750.945686.445624.672548.729486.911436.993379.232312.177265.628199.81158.013119.28580.50857.31743.73544.08437.71938.41637.53
Goodwill 1.3471.3562.4972.54714.07614.15114.13114.11615.20715.24515.28415.28721.5251.471.3841.3841.448000
Intangible Assets 16.07818.64822.62123.81125.46526.42327.26226.0227.35225.48219.7219.6428.2642.4672.3012.131.9970.9010.3580.349
Goodwill and Intangible Assets 17.42520.00425.11826.35839.54140.57441.39340.13642.55940.72735.00434.92929.7893.9373.6853.5143.4450.9010.3580.349
Long Term Investments 96.73485.40735.87116.02918.7218.46714.55913.9888.0727.2827.04611.2781.7361.750.52842.33843.3735.88300
Tax Assets 016.50616.45815.0456.3355.093.0863.7023.9495.70117.56211.84211.0067.5255.0834.9114.1592.73700
Other Non-Current Assets 189.67161.329-16.458-15.045-6.335-5.09-3.086-3.702-3.949-5.701-17.562-11.842-11.006-7.525-5.083-47.249-47.529-38.6211.62810.709
Total Non-Current Assets 1,117.5441,034.191747.434667.059606.99545.952492.945433.356362.808313.637241.86204.22150.8186.19561.5347.24947.52938.6250.40248.588
Total Assets 3,331.8673,387.3023,384.3212,546.3832,144.2942,233.8681,888.0631,447.4061,439.808889.411881.952916.976897.672504.264245.565226.032214.356182.07494.1792.38
Liabilities & Equity:
Current Liabilities:
Account Payables 59.20539.95940.32855.75532.86730.17627.24423.37622.73317.62713.93311.1878.9128.1544.4634.3523.9822.4142.1932.87
Short Term Debt 31.02465.87844.66144.78514.0858.03125.29247.2350.91618.77718.53310.5020.6050001.237008.172
Tax Payables 025.56929.8816.15313.64515.84627.6398.3617.2354.0447.52617.30219.29414.015.3245.6656.2414.59800
Deferred Revenue 203.15-8.867-44.661-44.785-14.085-8.031-25.292-47.23-50.916-18.777-18.533-10.502-0.605000-1.237000
Other Current Liabilities 239.618397.841397.576490.223479.964383.129394.041304.535255.953206.878149.602142.328119.631264.56234.38534.86331.11728.4821.54618.146
Total Current Liabilities 532.997494.811437.904545.978512.831413.305421.285327.911278.686224.505163.535153.515128.543272.71638.84839.21535.09930.89423.73929.188
Non-Current Liabilities:
Long Term Debt 846.146351.112771.206567.227461.431381.8618.2141.261.4871.7482.04-4.018-4.219-2.887-2.428-2.349-2.481000
Deferred Revenue Non-Current 064.67816.42518.177245.779258.113266.559288.547260.379281.67247.938266.145262.6852.8872.4282.3492.4811.93200
Deferred Tax Liabilities Non-Current 05.6225.8928.0129.9417.739.8037.037.6995.5825.334.01720.3420.3240.4470.167000
Other Non-Current Liabilities 128.517426.725-22.317-26.189-255.72-265.843-276.362-295.577-268.078-287.252-253.2684.0184.2192.8872.4282.3492.481000
Total Non-Current Liabilities 974.663848.137771.206567.227461.431381.8618.2141.261.4871.7482.04270.162264.6853.2292.7522.7962.6481.93200
Total Liabilities 1,507.661,342.9481,298.2771,183.7151,255.934846.175728.71631.815554.357517.113422.953423.677393.228275.94541.642.01137.74732.82623.73929.188
Equity:
Preferred Stock 0611.5150000008.8810.02110.56914.1859.949.45918.49923.40616.12414.11300
Common Stock 2.1262.1212.1162.1112.1082.0962.0811.9541.9181.8791.861.8361.8341.7341.7151.6921.6691.60.3640.05
Retained Earnings -772.84-611.515-595.829-502.248-654.073-275.397-266.128-175.006-83.15329.93999.505126.913121.216104.76493.62381.27668.29755.10643.34837.602
Accumulated Other Comprehensive Income/Loss 19.2841,398.40334.11849.57364.43160.77535.86524.922-8.88-10.021-10.569-14.185-9.94-9.459-18.499-23.406-16.124-14.11325.28324.062
Other Total Stockholders Equity 1,966.348-9.4451,914.1961,461.1051,344.8811,258.5181,239.061,049.8351,024.596350.986352.536349.915364.701111.311101.94494.645100.35592.54200
Total Shareholders Equity 1,214.9181,391.0791,354.6011,010.541757.3471,045.9921,010.878901.705943.361382.804453.901478.664487.751217.809197.282177.613170.321149.24868.99561.714
Total Equity 1,824.2072,044.3542,086.0441,362.668888.361,387.6931,159.353815.591885.451372.298458.999493.299504.444228.319203.965184.021176.609149.24868.99561.747
Total Liabilities & Shareholders Equity 3,331.8673,387.3023,384.3212,546.3832,144.2942,232.771,888.0631,447.4061,439.808889.411881.952916.976897.672504.264245.565226.032214.356182.07492.73490.935